Who
Steven M. Rales
Chairman
Company insider
Files Form 4 as: Chairman, Danaher; Director, Fortive; 10% owner, Enovis.
In numbers
- Trades disclosed
- 82
- Buys
- 1
- Sells
- 17
- Bought
- $50.0M
- Sold
- $2.4B
- Companies
- 3
- Companies where not an officer
- 2
- First trade
- 25 Oct 2006
- Last trade
- 9 Oct 2026
- Last filed
- 14 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 9 Oct 2026filed 14 Oct 2026 | DHR DanaherLife-science tools | SEC FORM 4 Code D | —500,000 at $0.00 | filing |
| 4 Aug 2026filed 6 Aug 2026 | DHR DanaherLife-science tools | SEC FORM 4 Code A | —500,000 at $0.00 | filing |
| 4 Aug 2026filed 6 Aug 2026 | DHR Danaheroption or derivative · Life-science tools | SEC FORM 4 Code A | —1,000,000 at $0.00 | filing |
| 4 Aug 2026filed 6 Aug 2026 | DHR Danaheroption or derivative · Life-science tools | SEC FORM 4 Code A | —1,000,000 at $0.00 | filing |
| 4 Aug 2026filed 6 Aug 2026 | DHR DanaherLife-science tools | SEC FORM 4 Code A | —500,000 at $0.00 | filing |
| 12 May 2025filed 14 May 2025 | DHR DanaherLife-science tools | SEC FORM 4 Sold | $32.3M166,225 at $194.08 | filing |
| 12 May 2025filed 14 May 2025 | DHR DanaherLife-science tools | SEC FORM 4 Sold | $69.3M355,668 at $194.97 | filing |
| 12 May 2025filed 14 May 2025 | DHR DanaherLife-science tools | SEC FORM 4 Sold | $21.5M109,801 at $195.69 | filing |
| 12 May 2025filed 14 May 2025 | DHR DanaherLife-science tools | SEC FORM 4 Sold | $37.3M189,314 at $197.06 | filing |
| 12 May 2025filed 14 May 2025 | DHR DanaherLife-science tools | SEC FORM 4 Sold | $11.5M58,313 at $197.86 | filing |
| 12 May 2025filed 14 May 2025 | DHR DanaherLife-science tools | SEC FORM 4 Sold | $32.7M164,412 at $199.15 | filing |
| 12 May 2025filed 14 May 2025 | DHR DanaherLife-science tools | SEC FORM 4 Sold | $31.7M158,951 at $199.67 | filing |
| 12 May 2025filed 14 May 2025 | DHR DanaherLife-science tools | SEC FORM 4 Sold | $9.5M47,316 at $200.83 | filing |
| 17 Apr 2023filed 17 Apr 2023 | DHR Danaheroption or derivative · Life-science tools | SEC FORM 4 Code C | —25,000 at $0.00 | filing |
| 17 Apr 2023filed 17 Apr 2023 | DHR DanaherLife-science tools | SEC FORM 4 Code C | $25.0M125,437 at $199.30 | filing |
| 24 Oct 2022filed 26 Oct 2022 | DHR DanaherLife-science tools | SEC FORM 4 Code J | $20.9M84,582 at $247.16 | filing |
| 19 Sep 2022filed 21 Sep 2022 | DHR DanaherLife-science tools | SEC FORM 4 Code J | $7.8M28,280 at $276.05 | filing |
| 8 Aug 2022filed 6 Feb 2023 | DHR DanaherLife-science tools | SEC FORM 4 Code G | —1,285,075 at $0.00 | filing |
| 28 Jun 2021filed 14 Feb 2022 | DHR DanaherLife-science tools | SEC FORM 4 Code G | —512,156 at $0.00 | filing |
| 11 Jun 2021filed 14 Feb 2022 | DHR DanaherLife-science tools | SEC FORM 4 Code G | —6,100,000 at $0.00 | filing |
News
Roper Technologies (ROP) vs. Danaher (DHR): Which Is the Better Long-Term Capital Allocator?DHR · insidermonkey.com · 18 Oct 2026Willow Creek Capital Management Inc. Purchases 2,796 Shares of Danaher Corporation $DHRDHR · dailypolitical.com · 17 Oct 2026Danaher's Stock Is Pricing in a Recovery. Can Its Earnings Deliver?DHR · insidermonkey.com · 16 Oct 2026Enovis (NYSE:ENOV) and electroCore (NASDAQ:ECOR) Head to Head SurveyENOV · themarketsdaily.com · 11 Oct 2026Enovis (NYSE:ENOV) versus electroCore (NASDAQ:ECOR) Financial ContrastENOV · tickerreport.com · 9 Oct 2026Enovis (NYSE:ENOV) Sets New 12-Month Low – Here's WhyENOV · dailypolitical.com · 8 Oct 2026
0 headlines in the last 90 days name Steven M. Rales; 6 articles from the last 14 days about the 3 companies they traded most, at most three about any one of them.